Philip Scheltens, Chair of the EFNS Scientist Panel Cognitive Neurology and Dementia
Event marks major milestone in EAN’s strategic efforts to shape the future of neurology and strengthen collaboration at both European and national levels.
Latest Posts
-
-
Grand Rounds
Case report: A 29-year-old man with rapid onset tetraplegia and respiratory insufficiency
May 1, 2012by Svein Ivar Bekkelund A 29-year-old man with a history of moderate autism and diabetes mellitus treated with insulin presented with a 2-week history of malaise, progressive pareses in both legs and slight weakness in both arms. The last two… Continue Reading -
Chapters in the history of Swedish Neuroscience – Swedish Academic Neurology: a brief outline by Sten Fredrikson This year, 2012, it is 125 years since the first chair of neurology was established at Karolinska Institutet in Stockholm. 1887, only a… Continue Reading
-

by Alexandre Bisdorff The European Union of Medical Specialists (UEMS: Union Européenne des Médecins Spécialistes) is a professional European organization of doctors (except general practitioners).
The UEMS was founded in 1958 and is constituted by the national medical associations of… Continue Reading -
Research agenda. The European Brain Council have updated their 2006 consensus document on brain research (Di Luca,M. et al. 2011 Consensus document on European brain research. Eur. J. Neurosci. 33, 768-818). In a 50 page paper covering 43 topics Monica Di Luca and colleagues, including Past EFNS President Jes Olesen, have focused on seven fields:
-
In 2011 I performed a scientific fellowship on the role of the plasminogen system in pneumococcal meningitis at the Klinikum Grosshadern, Ludwig-Maximilians-Universität, in Munich, Germany which was funded by an EFNS scientific fellowship grant.
-
Space is limited – please make sure to register early via the congress website! www.efns.org/efns2012 Saturday, September 8, 2012 9.30-11.00
Free Teaching Course: How do I examine…? 11.30 – 13.30
Teaching Course 1: Movement disorders – basic clinical knowledge
Teaching… Continue Reading -
At the last two EFNS congresses (Geneva & Budapest) we made recordings of selected presentations, launching the concept of “webcasting”. This has proved to be valuable reference material, especially for those who couldn’t make it to the congress, missed certain… Continue Reading
-
EAN News
EFNS Congress Evaluation: Winners of a Free Registration to the 16th EFNS Congress in Stockholm, Sweden, September 08-11, 2012
May 1, 2012We thank all congress participants who filled in the evaluation forms at the 15th EFNS Congress in Budapest – Your feedback helps us to improve our congresses and scientific programme! Among all evaluation forms received, five free registrations to the… Continue Reading -
Other News
The Open Facilities for Training in European Neurology (OFTEN): an emerging pan-European exchange programme for junior neurologists
May 1, 2012Countries of the European Union (EU) have been harmonized to a single market with free movement of citizens, goods, services and finances. This historic achievement also greatly facilitates training abroad.
The European Board of Neurology (EBN, www.uems-neuroboard.org) initiated an exchange… Continue Reading -
EBC confirms it will go ahead with the Year of the Brain in 2014 but withdraws from the institutionally led process. EBC communicated at length with European Commission President Barroso, his team and the different Directorate Generals over the last… Continue Reading
-
Top 10 Articles
Top Article: Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort
April 1, 2012Abstract: Objective: Mutations in the FUS gene on chromosome 16 have been recently discovered as a cause of familial amyotrophic lateral sclerosis (FALS). This study determined the frequency and identities of FUS gene mutations in a cohort of Italian patients… Continue Reading -
Luca Pani is Director General of the Italian Medicines Agency. Paolo Siviero is Head of the Department of Economic Strategy and Pharmaceutical policy – Italian Medicines Agency.
-
by Markus Gschwind The patient was a 51-year-old car mechanic, without any previous illness apart from untreated arterial hypertension. One morning, on waking very early to go to work, he felt a strange dizziness. During breakfast he fell asleep twice… Continue Reading
-
The Challenge Neuropathy in Parkinson disease: prevelance and determinants
Abstract:
Objective: To ascertain the prevalence and determinants of neuropathy in patients with Parkinson disease (PD), in particular, the roles of vitamin B12 and levodopa exposure.
Methods: We performed a cross-sectional… Continue Reading









